CSCS

Propanc Biopharma Establishes Joint Research Collaboration Agreement with the Universities of Jaén and Granada

Retrieved on: 
Wednesday, August 3, 2022 - 2:00pm

Propanc Biopharma, Inc. (OTCQB: PPCB) (Propanc or the Company), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that a Joint Research Collaboration Agreement has been established with the Universities of Jan and Granada, Spain.

Key Points: 
  • Propanc Biopharma, Inc. (OTCQB: PPCB) (Propanc or the Company), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that a Joint Research Collaboration Agreement has been established with the Universities of Jan and Granada, Spain.
  • The work is being conducted at the laboratory of Professor Macarena Pern PhD, who is the lead researcher on the project and is the second Joint Research Collaboration Agreement currently in progress with the two Spanish Universities.
  • This process of reversing the tumor phenotype, called differentiation, is how proenzymes exert anti-tumor, anti-cancer and anti-metastatic effects.
  • Propanc will own any intellectual property developed during the research, and publishing rights, in exchange for any net future royalties from intellectual property rights.

CITIC Telecom CPC expands global footprint with new SmartCLOUD(TM) Service Centers in Tallinn and New York

Retrieved on: 
Monday, August 1, 2022 - 10:57am

"Additional SmartCLOUD(TM) Service Centers, are located at Tallinn, Estonia and New York, US in Q3, 2022.

Key Points: 
  • "Additional SmartCLOUD(TM) Service Centers, are located at Tallinn, Estonia and New York, US in Q3, 2022.
  • It also marks a milestone toward further enhancing CITIC Telecom CPC's already extensive capability to provide diverse and effective cloud services to Europe-based enterprise customers," said Mr.
  • Serve Bunnik, Deputy Director, European Operations, CITIC Telecom CPC.
  • To keep pace with digital transformation, infrastructure complexity and dynamic business operation across the globe, CITIC Telecom CPC expands its global footprint with 2 new cloud platforms, integrated all-in-one comprehensive network-cloud solution in the region, connecting West-East with Global Cloud Ring.

Propanc Biopharma’s CSO Reflects on Unique Anti-Cancer Effects of PRP Discovered Over Past Decade

Retrieved on: 
Thursday, July 28, 2022 - 2:00pm

PRP is a proenzyme therapy for the treatment and prevention of metastatic cancer from solid tumors.

Key Points: 
  • PRP is a proenzyme therapy for the treatment and prevention of metastatic cancer from solid tumors.
  • This unique approach could become an effective tool in the fight against metastatic cancer, which is the main cause of patient death for sufferers.
  • When CSCs undergo the EMT process, they become motile and invasive, with an ability to spread into surrounding tissues.
  • Further research is in progress with the Companys joint research partners focusing on the effects of PRP on the tumor microenvironment.

Propanc Biopharma’s CEO Comments on the 39 Granted Patents and 26 Patent Applications Under Examination in Key Global Jurisdictions

Retrieved on: 
Tuesday, July 5, 2022 - 2:00pm

Presently, there are 39 granted patents and a further 26 patent applications under examination in key global jurisdictions relating to proenzymes as an effective therapeutic agent against solid tumors, covering the lead product candidate, PRP.

Key Points: 
  • Presently, there are 39 granted patents and a further 26 patent applications under examination in key global jurisdictions relating to proenzymes as an effective therapeutic agent against solid tumors, covering the lead product candidate, PRP.
  • The Companys patent portfolio covers compositions of the PRP formulation and method of use claims for the treatment of solid tumors by targeting and eradicating cancer stem cells.
  • The fact there was limited prior art meant that our approach to cancer is unique if we could identify a novel formulation.
  • Over a decade later, we have filed multiple patents covering compositions of proenzymes and a method to treat metastatic cancer by targeting CSCs.

Athletico Physical Therapy Opens in Lexington - Leestown

Retrieved on: 
Wednesday, June 22, 2022 - 2:00pm

LEXINGTON, Ky., June 22, 2022 /PRNewswire/ -- Athletico Physical Therapy has opened a new location in Lexington, Kentucky, located in Townley Center Shoppes next to Domino's Pizza. This location offers convenient hours, including early morning and late evening appointments, and does not require a referral or prescription to start treatment. To learn more, or to schedule a free assessment, visit www.athletico.com/LexingtonLeestown

Key Points: 
  • LEXINGTON, Ky., June 22, 2022 /PRNewswire/ --Athletico Physical Therapy has opened a new location in Lexington, Kentucky, located in Townley Center Shoppes next to Domino's Pizza.
  • In addition to in-clinic treatment at Lexington Leestown, Athletico is also offering telehealth virtual treatment options where patients can connect with a physical therapist through a secure online video chat.
  • "As clinic manager, I look forward to serving the Lexington community in which I live," said Cameron Richey, PT, DPT, CSCS and Clinic Manager of Athletico Lexington Leestown.
  • Services available at Athletico Lexington Leestown include:
    Physical therapy Our physical therapists treat you to reduce pain, improve or restore mobility, and to help you remain at your optimal health without further risk of injury.

Train4Birth Launches a New Approach to Perinatal Healthcare

Retrieved on: 
Wednesday, June 22, 2022 - 1:07pm

Train4Birth is a virtual program including body awareness and pelvic floor education, customizable exercises, and coaching to immediately address daily pregnancy challenges.

Key Points: 
  • Train4Birth is a virtual program including body awareness and pelvic floor education, customizable exercises, and coaching to immediately address daily pregnancy challenges.
  • I wanted to start a parent friendly, affordable, and proactive approach to perinatal therapy, says Dr. Patel.
  • With Train4Birth parents can access evidence-based information and doctoral level personalized guidance at their own convenience, in realistic 5-minute doses from home or work.
  • The goal of Train4Birth is to help parents achieve these recommendations and health benefits in a safe way that meets individual goals.

Pyx Health Takes Giant Leap in Addressing Chronic Loneliness with THRIVE Pathway

Retrieved on: 
Thursday, June 16, 2022 - 1:56pm

TUCSON, Ariz., June 16, 2022 /PRNewswire/ -- Pyx Health, a tech-enabled services company that provides health plans and their members an innovative, scalable solution that effectively addresses the nation's critical loneliness epidemic, today announced its groundbreaking THRIVE Pathway program. The project concluded its six-month pilot with impressive results, showing a 47% increased improvement in the ability to reduce loneliness.

Key Points: 
  • THRIVE Pathway was designed to break the cycle of chronic loneliness with the understanding that this condition isn't merely about isolation.
  • When defined as a health ailment, loneliness refers to how individuals feel about the quantity and quality of their social interactions.
  • The science behind loneliness continues to correlate it to harmful impacts on physical and mental health.
  • Cindy Jordan, CEO of Pyx Health, said, "THRIVE is a successful and tangible solution that lessens the impact of loneliness.

CBD Move Free Partners with Rise Nation to Launch New Topical Balm for Post-Workout Relief

Retrieved on: 
Wednesday, June 15, 2022 - 1:17pm

BELLEVUE, Wash., June 15, 2022 /PRNewswire/ -- CBD Move Free, a line of unique CBD relief products designed to maximize everyday life, is today announcing a collaboration with Rise Nation, a rapidly growing brand of safe and effective science-based workout studios. Their partnership will result in a new product within the CBD Move Free line which is designed to help Rise Nation clients and workout enthusiasts alike by relieving delayed onset muscle soreness and exercise induced muscle damage, which naturally occurs after physical activity due to microscopic damage to muscle fiber's.

Key Points: 
  • To help Rise Nation clients alleviate sore muscles while reducing inflammation and joint discomfort after a tough workout, this product will be sold in the New York City, Dallas, Chicago and Cleveland Rise Nation locations to start, with plans to distribute the balm to the other Rise Nation studios.
  • This balm marks the beginning of future collaborations to come between CBD Move Free and Rise Nation.
  • "We are so excited to be working with such a respected fitness brand like Rise Nation to provide its clients with relief after a hard workout," said Jonas Roeser, CEO and co-founder of CBD Move Free.
  • CBD Move Free is the dba of JPS Products, Inc. JPS Products, Inc. also operates the brands Hemp Move Free and JPS Move Free.

Propanc Biopharma’s PRP to Target 80 – 90% of Cancer Cases

Retrieved on: 
Tuesday, June 14, 2022 - 2:00pm

Propanc Biopharma, Inc. (OTCQB: PPCB) (Propanc or the Company), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that the Companys lead product candidate, PRP, targets solid tumors, which accounts for 80 90% of cancer cases, according to the National Cancer Institute.

Key Points: 
  • Propanc Biopharma, Inc. (OTCQB: PPCB) (Propanc or the Company), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that the Companys lead product candidate, PRP, targets solid tumors, which accounts for 80 90% of cancer cases, according to the National Cancer Institute.
  • CSCs is the mechanism by which cancer is able to return and spread, even post standard treatments.
  • PRP reverses the transition to a CSC and as such, reduces the metastatic potential of the tumor cells.
  • Dr Kenyon said, Based on the mode of action, PRP targets 80 to 90% of all cancers, which is highly significant.

Tizeti names Emmanuel Ikazoboh as new Chairman, appoints new board members

Retrieved on: 
Tuesday, June 7, 2022 - 1:00pm

LAGOS, Nigeria, June 07, 2022 (GLOBE NEWSWIRE) -- Tizeti Network Limited, West Africas pioneer solar-based internet service provider has today, announced the appointment of Emmanuel Ikazoboh as its Board Chairman.

Key Points: 
  • LAGOS, Nigeria, June 07, 2022 (GLOBE NEWSWIRE) -- Tizeti Network Limited, West Africas pioneer solar-based internet service provider has today, announced the appointment of Emmanuel Ikazoboh as its Board Chairman.
  • The companys impact over the last nine years and ongoing transformation reveal the opportunities ahead, especially in a digital economy.
  • Tizeti has a deserved reputation for its innovative products and disruptive approach, and I look forward to serving as its Board Chairman, said Ikazoboh.
  • The other new members of the Tizeti board include Engr.